Talphera announces private placement financing of up to $29M priced at-the market
Source: SeekingAlpha
2025-09-08 08:49:22 ET
More on CorMedix, Talphera
- CorMedix: The Undervalued Breakthrough
- Talphera outlines accelerated NEPHRO enrollment and lowers 2025 cash operating expense guidance amid protocol shift
- CorMedix slides after pricing $85M stock offering
Read the full article on Seeking Alpha
For further details see:
Talphera announces private placement financing of up to $29M priced at-the market
Talphera Inc.
NASDAQ: TLPH
TLPH Trading
-7.66% G/L:
$0.7955 Last:
47,338 Volume:
$0.80 Open:
TLPH Latest News
March 02, 2026 08:30:00 am
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial
November 12, 2025 04:05:00 pm
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 12, 2025 09:28:49 am
Spider Silk, Strong Earnings, and Biotech Resilience Define the Midweek Momentum
November 05, 2025 04:05:00 pm
Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025
TLPH Stock Data
$39,152,079
25,309,023
0.41%
12
N/A
Pharmaceuticals
Healthcare
US
San Mateo
